Loading…
Oscar Health, Inc. is projected to rise to $49.02 by 2027, a +57% move from its current price of $31.23. OSCR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $30.23 | $31.28 | $32.36 | +0.15% |
| Aug 2 | $29.85 | $31.32 | $32.87 | +0.30% |
| Aug 3 | $29.57 | $31.37 | $33.28 | +0.45% |
| Aug 4 | $29.34 | $31.42 | $33.64 | +0.60% |
| Aug 5 | $29.15 | $31.46 | $33.96 | +0.75% |
| Aug 6 | $28.98 | $31.51 | $34.26 | +0.90% |
| Aug 7 | $28.83 | $31.56 | $34.54 | +1.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $28.83 | $31.56 | $34.54 | +1.05% |
| Week 2 | $28.07 | $31.89 | $36.24 | +2.12% |
| Week 3 | $27.56 | $32.23 | $37.68 | +3.19% |
| Week 4 | $27.18 | $32.57 | $39.01 | +4.28% |
| Week 5 | $26.89 | $32.91 | $40.28 | +5.38% |
| Week 6 | $26.66 | $33.26 | $41.49 | +6.49% |
| Week 7 | $26.46 | $33.61 | $42.68 | +7.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products.
In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc.
in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Oscar Health, Inc. (OSCR) operates in the Healthcare sector and carries a current price of $31.40 with a market cap of $9.47B. It is ranked 923 by market position. The current price aligns with the 2026 forecast, which shows an avg of $31.40 and a neutral sentiment for that year.
A major floor 65.3% below — a decisive break under it would weaken the trend.
The nearest floor, 9.7% below — buyers have tended to step in here.
The nearest ceiling, 3.0% above — a clean break opens room to run.
A major ceiling 10.5% above — clearing it would confirm fresh momentum.
Key OSCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OSCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.95 | Buy | $30.41 | Buy |
| MA 10 | $29.76 | Buy | $30.12 | Buy |
| MA 20 | $30.35 | Buy | $29.83 | Buy |
| MA 50 | $27.82 | Buy | $27.53 | Buy |
| MA 100 | $21.89 | Buy | $24.05 | Buy |
| MA 200 | $18.87 | Buy | $20.81 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.72 | Neutral |
| Stoch RSI (14) | 65.02 | Neutral |
| CCI (20) | 58.75 | Neutral |
| Williams %R (14) | -10.85 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | 0.51 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 89.15 | Sell |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | 0.11 | Buy |
| Ultimate (7,14,28) | 53.40 | Neutral |
| Momentum (10) | 2.37 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 30.89 | Buy |
| ADX (14) | 18.64 | Neutral |
| ATR (14) | 0.90 | Info |
The 30-day technical picture is bullish, with sentiment listed as BULLISH and RSI14 at 50. The asset’s near-term moving averages are SMA50 at $27.39 and SMA200 at $18.71, providing near-term contextual support and resistance. Key levels include support at $28.19 and resistance at $32.18, framing a plausible trading range over the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.85 | $31.23 | $49.19 | 0% | Neutral | |
| $38.20 | $49.02 | $67.02 | +57% | Bullish | |
| $42.23 | $56.19 | $80.40 | +80% | Bullish | |
| $51.33 | $70.39 | $104.31 | +125% | Bullish | |
| $52.14 | $73.45 | $112.07 | +135% | Bullish | |
| $54.92 | $79.28 | $124.08 | +154% | Bullish | |
| $69.04 | $101.96 | $163.23 | +226% | Bullish | |
| $85.08 | $128.39 | $209.80 | +311% | Bullish | |
| $98.72 | $152.09 | $253.21 | +387% | Bullish | |
| $102.70 | $161.38 | $273.37 | +417% | Bullish | |
| $165.78 | $285.37 | $519.59 | +814% | Bullish | |
| $277.37 | $561.66 | $1,134.45 | +17.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.85 | $31.23 | $36.50 | +0.00% |
| August 2026 | $28.35 | $33.45 | $40.52 | +7.11% |
| September 2026 | $30.02 | $35.80 | $44.09 | +7.02% |
| October 2026 | $30.16 | $36.26 | $45.25 | +1.30% |
| November 2026 | $30.39 | $36.79 | $46.39 | +1.46% |
| December 2026 | $31.72 | $38.65 | $49.19 | +5.04% |
Click any year to see its month-by-month OSCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Oscar Health, Inc.'s 2026 outlook centres on $31.23, within a $10.85 to $49.19 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, OSCR could reach as high as $67.02, with a base case around $49.02 and support toward $38.20 — roughly +57% from $31.23. Buyers look set to stay in control over this stretch.
Expect OSCR to range from $42.23 to $80.40 through 2028. The $56.19 average target implies a +80% move from current prices. That is up +15% on the projected 2027 average. Momentum favours further upside here.
The OSCR price prediction for 2029 points to an average of $70.39 (low $51.33, high $104.31) — a potential gain of +125% on today's $31.23. Buyers look set to stay in control over this stretch.
In 2030, OSCR is projected to trade between $52.14 and $112.07, averaging $73.45 — a potential gain of +135% from today's $31.23. That is up +4% on the projected 2029 average. Momentum favours further upside here.
Oscar Health, Inc.'s 2031 outlook centres on $79.28, within a $54.92 to $124.08 range. That is up +8% on the projected 2030 average. That marks a +154% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, OSCR could reach as high as $163.23, with a base case around $101.96 and support toward $69.04 — roughly +226% from $31.23. Momentum favours further upside here.
Expect OSCR to range from $85.08 to $209.80 through 2033. The $128.39 average target implies a +311% move from current prices. That is up +26% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The OSCR price prediction for 2034 points to an average of $152.09 (low $98.72, high $253.21) — a potential gain of +387% on today's $31.23. Momentum favours further upside here.
In 2035, OSCR is projected to trade between $102.70 and $273.37, averaging $161.38 — a potential gain of +417% from today's $31.23. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Oscar Health, Inc.'s 2040 outlook centres on $285.37, within a $165.78 to $519.59 range. That is up +77% on the projected 2035 average. That marks a +814% change versus current levels. Momentum favours further upside here.
By 2050, OSCR could reach as high as $1,134.45, with a base case around $561.66 and support toward $277.37 — roughly +17.0x from $31.23. Buyers look set to stay in control over this stretch.
Investing $1,000 in OSCR today (≈ 32.020493 OSCR) could be worth
$17,984.66
+$16,984.66 (+1698%) by 2050 · US Dollar
Based on the average projected OSCR price of $561.66 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OSCRwould be worth at today's price.
$1,000 invested in OSCR on Jul 30, 2025 (≈ 71.428571 OSCR) would be worth
$2,230.71
+$1,230.71 (+123.1%) today · 2.23× · US Dollar
Based on a OSCR entry price of $14 vs. today's $31.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $28.92 | $1,079.88 | +8.0% |
| 1 month ago | $28.52 | $1,095.02 | +9.5% |
| 3 months ago | $18.49 | $1,689.02 | +68.9% |
| 6 months ago | $14.35 | $2,176.31 | +117.6% |
| 1 year ago | $14 | $2,230.71 | +123.1% |
| All time (5.0y) ago | $16.2 | $1,927.78 | +92.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OSCR forecast.
Our base-case forecast reaches $62.00 around 2029.
Implied market cap at $62.00: $16.49B
The multi-year forecast shows a bullish trajectory with rising averages and sizable upside potential. For 2027 the avg is $48.70 with a 55.1% ROI and bullish sentiment; 2028 shows an avg of $56.76 with an 80.8% ROI and bullish sentiment; 2029 an avg of $70.84 with a 125.6% ROI and bullish sentiment. The path continues to 2030 (avg $74.70, ROI 137.9%), 2031 (avg $81.25, ROI 158.8%), 2032 (avg $101.86, ROI 224.4%), 2033 (avg $126.34, ROI 302.4%), 2034 (avg $150.92, ROI 380.6%), and 2035 (avg $162.21, ROI 416.6%).
Looking further, 2040 shows an avg of $282.35 with a 799.2% ROI, and 2050 shows an avg of $565.63 with a 1,701.4% ROI. The sentiment remains bullish across the longer horizon, though these figures are estimates and not guarantees. Uncertainty and downside risk are inherent in any forecast.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $74.70 with a min of $54.52 and a max of $110.59, and a projected ROI of 137.9% with bullish sentiment.
Forecasts indicate a bullish trajectory beginning 2027, with rising averages through 2050 and ROI values up to 1,701.4% by 2050. 2026 is neutral with an avg of $31.40 and a 0% ROI, while subsequent years show bullish sentiment and higher ROI.
Yes. The 2050 max forecast is $1,081.93, indicating a potential to exceed $1,000 in the long term.
Current price is $31.40 and market cap is $9.47B.
The 30-day range is $25.79 to $38.24.
Oscar Health, Inc. Community Discussion
0Share your Oscar Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.